Results
1 -
10 of
80New Agents for Multiple Myeloma, Multiple Myeloma Novel Proteasome Inhibitors, Advances in Biology and Therapy of Multiple Myeloma Light Chain Amyloidosis, Biology and Management of Unusual Plasma Cell Dyscrasias Treatment of Patients in Third Relapse and Beyond Including Double-Refractory Disease, Personalized Therapy for Multiple Myeloma Proteasome Inhibitors in the Treatment of Multiple Myeloma and AL Amyloidosis, Resistance to Proteasome Inhibitors in Cancer Targeting the Proteasome Pathway for the Treatment of Solid Tumors, Resistance to Proteasome Inhibitors in Cancer Treatment of Patients in First or Second Relapse, Personalized Therapy for Multiple Myeloma Treatment of MM: Upcoming Novel Therapies, Plasma Cell Dyscrasias Resistance to Proteasome Inhibitors in Multiple Myeloma, Resistance to Proteasome Inhibitors in Cancer Second-Generation Proteasome Inhibitors, Bortezomib in the Treatment of Multiple Myeloma